Michelle Hoon-starr, AU.D. Audiologist Medicare: Medicare Enrolled Practice Location: 500 Washington Ave, Chestertown, MD 21620 Phone: 410-778-5170 Fax: 410-778-6195 |
Diamond G Prus, AU.D. Audiologist Medicare: Medicare Enrolled Practice Location: 500 Washington Ave, Chestertown, MD 21620 Phone: 410-778-5170 |
Mrs. Barbara J. Mclendon, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 818 High St, Suite 3, Chestertown, MD 21620 Phone: 410-778-5170 Fax: 410-778-6195 |
Stacie L Glover, M.S., CCC-A Audiologist Medicare: Accepting Medicare Assignments Practice Location: 818 High St, Chestertown, MD 21620 Phone: 410-778-5170 Fax: 410-778-6195 |
News Archive
Improper functioning of the mitochondria, a cell's source of energy, may help account for the fact that African-American men with prostate cancer respond poorly to the same conventional therapies provided to Caucasian-American men, according to research led by Dhyan Chandra, PhD, Associate Professor of Oncology in the Department of Pharmacology and Therapeutics at Roswell Park Cancer Institute.
Cytheris SA, a clinical-stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the publication of a case study report based on successful treatment of Progressive Multifocal Leukoencephalopathy (PML) with combination therapy consisting of two investigational agents, Cytheris' recombinant human interleukin-7 (CYT107) and CMX001, an investigational, oral broad-spectrum antiviral drug (Chimerix, Research Triangle Park, NC) in the Journal of Antimicrobial Chemotherapy.
Affymetrix, Inc. today announced plans to commercialize four Axiom population-optimized arrays used to analyze 100,000 samples collected from volunteers in one of the nation's largest and most diverse genomics projects funded by the National Institutes of Health.
Citing the dangers of marijuana, the lack of clinical research on a controlled substance with a high potential for abuse, and the physician's oath to "first, do no harm," the American Society of Addiction Medicine today issued a white paper recommending a halt to using the weed as a medicine in states where it has been declared legal.
› Verified 8 days ago